HomeHNSA • STO
add
Hansa Biopharma AB
Previous close
kr 30.40
Day range
kr 29.32 - kr 30.24
Year range
kr 19.58 - kr 42.98
Market cap
2.99B SEK
Avg Volume
968.89K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 30.80M | -36.70% |
Operating expense | 158.31M | 2.66% |
Net income | -148.26M | -42.83% |
Net profit margin | -481.29 | -125.65% |
Earnings per share | -1.75 | -14.38% |
EBITDA | -146.97M | -26.46% |
Effective tax rate | -0.47% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 252.07M | -54.46% |
Total assets | 741.10M | -21.22% |
Total liabilities | 1.30B | 3.27% |
Total equity | -560.74M | — |
Shares outstanding | 84.72M | — |
Price to book | -4.59 | — |
Return on assets | -46.76% | — |
Return on capital | -89.11% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -148.26M | -42.83% |
Cash from operations | -99.21M | 33.33% |
Cash from investing | — | — |
Cash from financing | -1.98M | -4.55% |
Net change in cash | -101.25M | 33.15% |
Free cash flow | -87.31M | 13.83% |
About
Founded
2007
Website
Employees
133
